SLC6A3 and Parkinson disease: MPTP in mice induces both behavioral and neurochemical changes that mimic human PD: altering free radicals quenching and reducing TH and dopamine transporter in the substantia nigra and striatum [27] result in motor impairments, bradykinesia and catalepsy [22].